Ming He

493 total citations
26 papers, 294 citations indexed

About

Ming He is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ming He has authored 26 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 8 papers in Oncology. Recurrent topics in Ming He's work include Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Ming He is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (10 papers) and Lung Cancer Treatments and Mutations (8 papers). Ming He collaborates with scholars based in China, Germany and Japan. Ming He's co-authors include Denggui Wen, Jianhui Zhang, Rui Wang, Gang Kuang, Lizhen Wei, Mario Sarbia, Nobuo Nomura, Yoshinori Nimura, Motohiro Mihara and Liwei Zhang and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and International Journal of Cancer.

In The Last Decade

Ming He

25 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming He China 9 167 144 109 81 42 26 294
Hiroki Harada Japan 10 104 0.6× 122 0.8× 80 0.7× 95 1.2× 94 2.2× 37 289
Zhongfa Xu China 10 223 1.3× 101 0.7× 162 1.5× 46 0.6× 34 0.8× 18 328
Haruyuki ANZAI Japan 9 100 0.6× 149 1.0× 69 0.6× 75 0.9× 63 1.5× 19 295
Akhila Wimalasingham United Kingdom 6 81 0.5× 110 0.8× 70 0.6× 90 1.1× 42 1.0× 10 210
Byung‐Noe Bae South Korea 11 199 1.2× 117 0.8× 81 0.7× 79 1.0× 69 1.6× 25 304
Anthony Kawesha United Kingdom 4 223 1.3× 99 0.7× 67 0.6× 35 0.4× 112 2.7× 5 276
Minhua Zhou China 4 122 0.7× 210 1.5× 35 0.3× 112 1.4× 72 1.7× 8 328
Sau Shung Fong Singapore 6 187 1.1× 140 1.0× 127 1.2× 33 0.4× 99 2.4× 12 356
G. Hommel Germany 7 118 0.7× 194 1.3× 106 1.0× 108 1.3× 40 1.0× 8 349
Ana‐Maria Dancau Germany 8 238 1.4× 108 0.8× 71 0.7× 176 2.2× 35 0.8× 8 326

Countries citing papers authored by Ming He

Since Specialization
Citations

This map shows the geographic impact of Ming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming He more than expected).

Fields of papers citing papers by Ming He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming He. The network helps show where Ming He may publish in the future.

Co-authorship network of co-authors of Ming He

This figure shows the co-authorship network connecting the top 25 collaborators of Ming He. A scholar is included among the top collaborators of Ming He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming He. Ming He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Xin, Hongyong Song, Xiaoyun Li, et al.. (2025). Disrupted minor intron splicing activates reductive carboxylation-mediated lipogenesis to drive metabolic dysfunction–associated steatotic liver disease progression. Journal of Clinical Investigation. 135(10). 2 indexed citations
2.
Zhou, Qiang, Bo Luo, Desheng Li, et al.. (2025). Case Report: A case study on the relationship between obesity and estrus in female captive panda. Frontiers in Veterinary Science. 12. 1552754–1552754.
3.
4.
Zhang, Yuan, Xiangxin Kong, Ke Song, et al.. (2024). Long-Term Protective Effects and Mechanisms of Gastric Bypass Surgery on the Kidneys in Hypertensive Obese Rat. Obesity Surgery. 34(4). 1257–1266. 2 indexed citations
5.
6.
He, Ming, Jie Li, Dan Li, et al.. (2021). Apatinib Combined with Paclitaxel and Cisplatin Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 37(4). 324–331. 4 indexed citations
7.
Li, Juan, Rong Qiu, Yuanping Hu, et al.. (2021). Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma. BioMed Research International. 2021(1). 8571438–8571438. 14 indexed citations
8.
Zhan, Qi, Yuanping Hu, Rong Qiu, et al.. (2021). Survival risk prediction model for patients with pT1–3 N0M0 esophageal squamous cell carcinoma after R0 esophagectomy with two-field lymphadenectomy for therapeutic purposes. Journal of Cardiothoracic Surgery. 16(1). 121–121. 1 indexed citations
9.
Dai, Liang, Ziming Wang, Zhiqiang Xue, et al.. (2020). Results of surgical treatment for primary malignant melanoma of the esophagus: A multicenter retrospective study. Journal of Thoracic and Cardiovascular Surgery. 161(1). 294–302. 13 indexed citations
10.
Liu, Yutao, Xuezhi Hao, Deruo Liu, et al.. (2020). <p>Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial</p>. Cancer Management and Research. Volume 12. 4633–4643. 9 indexed citations
11.
Xu, Xinjian, Yang� Yang, Limin Cao, et al.. (2019). Lymph Node Metastasis and Recurrence in Primary Small Cell Carcinoma of the Esophagus: A Retrospective Study of 125 Cases. Cancer Biotherapy and Radiopharmaceuticals. 34(7). 459–463. 5 indexed citations
12.
Wang, Yuxiang, Shilei Dong, Ming He, et al.. (2018). Analysis of risk factors of recurrence of pT1-3N0M0 esophageal squamous cell carcinoma after two-field esophagectomy. Zhonghua fangshe zhongliuxue zazhi. 27(2). 145–149. 2 indexed citations
13.
Gao, Yuhua, Yuxiang Wang, Jing Li, et al.. (2017). [Impact factor of postoperative prognosis of esophageal cancer patients with stage pT2N0~1M0].. PubMed. 39(9). 683–688. 2 indexed citations
14.
15.
16.
Wang, Yuxiang, Lili Wang, Jing Li, et al.. (2016). [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].. PubMed. 38(1). 48–54. 5 indexed citations
17.
Wang, Lei, et al.. (2008). Clinical analysis of 15 patients with adult-type pulmonary blastoma. Chinese Journal of Clinical Oncology. 5(5). 379–382. 2 indexed citations
18.
Zhang, Jianhui, Yan Li, Rui Wang, et al.. (2003). Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. International Journal of Cancer. 105(2). 281–284. 68 indexed citations
19.
Li, Yan, Rui Wang, Mario Sarbia, et al.. (2003). [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].. PubMed. 20(6). 544–6. 7 indexed citations
20.
Nimura, Yoshinori, Motohiro Mihara, Shingo Ichimiya, et al.. (1998). p73, a geme related top53, is not mutated in esophageal carcinomas. International Journal of Cancer. 78(4). 437–440. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Harada Breakdown of academic impact, for papers by Zhongfa Xu Breakdown of academic impact, for papers by Haruyuki ANZAI Breakdown of academic impact, for papers by Akhila Wimalasingham Breakdown of academic impact, for papers by Byung‐Noe Bae Breakdown of academic impact, for papers by Anthony Kawesha Breakdown of academic impact, for papers by Minhua Zhou Breakdown of academic impact, for papers by Sau Shung Fong Breakdown of academic impact, for papers by G. Hommel Breakdown of academic impact, for papers by Ana‐Maria Dancau
Rankless by CCL
2026